Profile
Lloyd Griese is currently the Vice President of Quality & Regulatory Compliance at SinuSys Corp.
He previously worked as the Director of Quality & Regulatory Compliance at Target Therapeutics, Inc. and Boston Scientific Corp., and as the Vice President of Quality & Regulatory Compliance at Benvenue Medical, Inc. Griese obtained an undergraduate degree from The California State University.
Lloyd Griese active positions
| Companies | Position | Start |
|---|---|---|
SinuSys Corp.
 SinuSys Corp. Medical SpecialtiesHealth Technology SinuSys Corp. develops medical device therapies to improve the sinus health of patients with chronic sinusitis. Its products include Vent-OS sinus dilation system, Restora steroid-eluting spacer, and SinuSys product pipeline. The company was founded by Jerome Hester and Thomas A. Schreck in 2010 and is headquartered in Palo Alto, CA. | General Counsel | - |
Former positions of Lloyd Griese
| Companies | Position | End |
|---|---|---|
Target Therapeutics, Inc.
 Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | General Counsel | - |
| BOSTON SCIENTIFIC CORPORATION | General Counsel | - |
Benvenue Medical, Inc.
 Benvenue Medical, Inc. Medical SpecialtiesHealth Technology Benvenue Medical, Inc. engages int the provision and development of invasive systems for spine repair. It offers Kiva an implant solution for vertebral augmentation and a departure from balloon kyphoplasty, Blazer-C a vertebral augmentation system that utilizes a unique cannulated curved wire offering mechanical channel creation, and Luna a interbody implant that is delivered through a minimally-invasive cannula to the disc space and expands in-situ. The company was founded by Laurent B. Schaller in 2004 and is headquartered in Santa Clara, CA. | General Counsel | - |
Training of Lloyd Griese
| The California State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Benvenue Medical, Inc.
Benvenue Medical, Inc. Medical SpecialtiesHealth Technology Benvenue Medical, Inc. engages int the provision and development of invasive systems for spine repair. It offers Kiva an implant solution for vertebral augmentation and a departure from balloon kyphoplasty, Blazer-C a vertebral augmentation system that utilizes a unique cannulated curved wire offering mechanical channel creation, and Luna a interbody implant that is delivered through a minimally-invasive cannula to the disc space and expands in-situ. The company was founded by Laurent B. Schaller in 2004 and is headquartered in Santa Clara, CA. | Health Technology |
Target Therapeutics, Inc.
Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Health Technology |
SinuSys Corp.
SinuSys Corp. Medical SpecialtiesHealth Technology SinuSys Corp. develops medical device therapies to improve the sinus health of patients with chronic sinusitis. Its products include Vent-OS sinus dilation system, Restora steroid-eluting spacer, and SinuSys product pipeline. The company was founded by Jerome Hester and Thomas A. Schreck in 2010 and is headquartered in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Lloyd Griese
